Skip to content

curcumin/Finding

One finding, on its own

A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.

  • curcumin — no detected effect on HOMA-IR

    Evidence strength: limited.FindingNull result
    “After 12 weeks of intervention, the mean (SD) serum HOMA-IR in the curcumin group was 2.11 (1.79) and in the placebo group it was 2.40 (2.11) which means no statistically significant difference between the two groups (P = 0.736).”
    Quoted verbatim from The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial..
    Study
    RCT
    Duration
    3 months
    Dose
    two 500 mg curcumin tablets together once daily (1000 mg a day) for twelve weeks
    Population
    Women aged 18 to 45 with polycystic ovary syndrome (Rotterdam criteria), BMI 18.5 to 40, in Eslamshahr, Iran

    The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial.2023PMID:3678853410.1186/s12902-023-01295-5Industry fundedPermalink

To cite this finding: https://catalystproject.ai/e/01M5RWYWMCQXW3BJC792M8YHJK

Keep reading